Viewing Study NCT05076695


Ignite Creation Date: 2025-12-24 @ 2:05 PM
Ignite Modification Date: 2026-01-01 @ 11:50 AM
Study NCT ID: NCT05076695
Status: UNKNOWN
Last Update Posted: 2021-10-13
First Post: 2021-09-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Neoadjuvant With Trastuzumab, Pyrotinib Plus Palbociclib and Fulvestrant in HER2-positive, ER-positive Breast Cancer
Sponsor:
Organization: